{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T05:33:41Z","timestamp":1779341621626,"version":"3.51.4"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007787","name":"National Research Centre","doi-asserted-by":"publisher","award":["10070107"],"award-info":[{"award-number":["10070107"]}],"id":[{"id":"10.13039\/100007787","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.ejps.2016.12.005","type":"journal-article","created":{"date-parts":[[2016,12,18]],"date-time":"2016-12-18T02:49:06Z","timestamp":1482029346000},"page":"75-84","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"special_numbering":"C","title":["Phospholipid complex enriched micelles: A novel drug delivery approach for promoting the antidiabetic effect of repaglinide"],"prefix":"10.1016","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5783-5215","authenticated-orcid":false,"given":"Ahmed Alaa","family":"Kassem","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sameh Hosam","family":"Abd El-Alim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona","family":"Basha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abeer","family":"Salama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2016.12.005_bb0005","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1021\/jf305143k","article-title":"Curcumin and genistein coloaded nanostructured lipid carriers: in vitro digestion and antiprostate cancer activity","volume":"61","author":"Aditya","year":"2013","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejps.2016.12.005_bb0010","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s40200-014-0119-9","article-title":"Amelioration of lipid peroxidation in vivo and in vitro by Satureja khozestanica essential oil in alloxan-induced diabetic rats","volume":"13","author":"Ahmadvand","year":"2014","journal-title":"J. Diabetes Metab. Disord."},{"key":"10.1016\/j.ejps.2016.12.005_bb0015","first-page":"19","article-title":"Lipid profile of alloxan-induced diabetic wistar rats treated with methanolic extract of Adansonia digitata fruit pulp","volume":"9","author":"Bako","year":"2014","journal-title":"Sci. World J."},{"key":"10.1016\/j.ejps.2016.12.005_bb0020","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ijpharm.2015.07.075","article-title":"Novel self-assembled nano-tubular mixed micelles of Pluronics P123, Pluronic F127 and phosphatidylcholine for oral delivery of nimodipine: in vitro characterization, ex vivo transport and in vivo pharmacokinetic studies","volume":"493","author":"Basalious","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2016.12.005_bb0025","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1046\/j.0306-5251.2003.01862.x","article-title":"CYP2C8 and CYP3A4 are the principal enzymes involved in the human in vitro biotransformation of the insulin secretagogue repaglinide","volume":"56","author":"Bidstrup","year":"2003","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2016.12.005_bb0030","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3109\/10717544.2012.752420","article-title":"A study on ethosomes as mode for transdermal delivery of an antidiabetic drug","volume":"20","author":"Bodade","year":"2013","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejps.2016.12.005_bb0035","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ijpharm.2012.05.009","article-title":"Huperzine A-phospholipid complex-loaded biodegradable thermosensitive polymer gel for controlled drug release","volume":"433","author":"Cai","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2016.12.005_bb0040","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ijpharm.2015.04.024","article-title":"Improve bile duct-targeted drug delivery and therapeutic efficacy for cholangiocarcinoma by cucurbitacin B loaded phospholipid complex modified with berberine hydrochloride","volume":"489","author":"Cheng","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2016.12.005_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/1635361","article-title":"Comparative study of the antioxidant effects of metformin, glibenclamide, and repaglinide in alloxan-induced diabetic rats","volume":"2016","author":"Chukwunonso Obi","year":"2016","journal-title":"J. Diab. Res."},{"key":"10.1016\/j.ejps.2016.12.005_bb0050","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.numecd.2010.10.016","article-title":"The burden of hospitalization related to diabetes mellitus: a population-based study","volume":"22","author":"De Berardis","year":"2012","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.ejps.2016.12.005_bb0055","doi-asserted-by":"crossref","first-page":"281","DOI":"10.7326\/0003-4819-131-4-199908170-00008","article-title":"Pharmacologic therapy for type 2 diabetes mellitus","volume":"131","author":"DeFronzo","year":"1999","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ejps.2016.12.005_bb0060","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1208\/s12249-013-9990-9","article-title":"Design and evaluation of self-nanoemulsifying pellets of repaglinide","volume":"14","author":"Desai","year":"2013","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejps.2016.12.005_bb0065","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ijpharm.2010.06.023","article-title":"In vitro characterization and in vivo toxicity study of repaglinide loaded poly (methyl methacrylate) nanoparticles","volume":"396","author":"Dhana lekshmi","year":"2010","journal-title":"Int. J. Pharm."},{"issue":"46","key":"10.1016\/j.ejps.2016.12.005_bb0070","first-page":"1","article-title":"Repaglinide-loaded solid lipid nanoparticles: effect of using different surfactants\/stabilizers on physicochemical properties of nanoparticles. DARU","volume":"23","author":"Ebrahimi","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2016.12.005_bb0075","first-page":"23","article-title":"Synthesis, characterization and discovery novel anti-diabetic and anti-hyperlipidemic thiazolidinedione derivatives","volume":"31","author":"Elhenawy","year":"2015","journal-title":"Int. J. Pharm. Sci. Rev. Res."},{"key":"10.1016\/j.ejps.2016.12.005_bb0080","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.3390\/ijms11052056","article-title":"Antioxidant protective effect of glibenclamide and metformin in combination with honey in pancreas of streptozotocin-induced diabetic rats","volume":"11","author":"Erejuwa","year":"2010","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejps.2016.12.005_bb0085","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1472-6882-7-29","article-title":"An experimental evaluation of the antidiabetic and antilipidemic properties of a standardized Momordica charantia fruit extract","volume":"7","author":"Fernandes","year":"2007","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.ejps.2016.12.005_bb0090","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1208\/s12249-014-0267-8","article-title":"Ultra rapidly dissolving repaglinide nanosized crystals prepared via bottom-up and top-down approach: influence of food on pharmacokinetics behavior","volume":"16","author":"Gadadare","year":"2015","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejps.2016.12.005_bb0095","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S2221-1691(12)60023-9","article-title":"Antidiabetic effect of Merremia emarginata Burm. F. in streptozotocin induced diabetic rats","volume":"2","author":"Gandhi","year":"2012","journal-title":"Asian Pac. J. Trop. Biomed."},{"key":"10.1016\/j.ejps.2016.12.005_bb0100","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.colsurfb.2010.07.029","article-title":"Design and ocular tolerance of flurbiprofen loaded ultrasound-engineered NLC","volume":"81","author":"Gonzalez-Mira","year":"2010","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.ejps.2016.12.005_bb0105","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.diabres.2004.09.018","article-title":"Effects of repaglinide on oxidative stress in tissues of diabetic rabbits","volume":"68","author":"Gumieniczek","year":"2005","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.ejps.2016.12.005_bb0110","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ijpharm.2014.08.006","article-title":"Application of phospholipid complex technique to improve the dissolution and pharmacokinetic of probucol by solvent-evaporation and co-grinding methods","volume":"474","author":"Guo","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2016.12.005_bb0115","first-page":"636","article-title":"Bioavailability of repaglinide, a novel antidiabetic agent, administered orally in tablet or solution form or intravenously in healthy male volunteers","volume":"36","author":"Hatorp","year":"1998","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2016.12.005_bb0120","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1208\/s12249-014-0229-1","article-title":"Bilayer matrix tablets for prolonged actions of metformin hydrochloride and repaglinide","volume":"16","author":"He","year":"2015","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejps.2016.12.005_bb0125","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ijpharm.2014.11.059","article-title":"Matrix tablets for sustained release of repaglinide: preparation, pharmacokinetics and hypoglycemic activity in beagle dogs","volume":"478","author":"He","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2016.12.005_bb0130","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1753-0407.2008.00001.x","article-title":"Repaglinide-loaded long-circulating biodegradable nanoparticles: rational approach for the management of type 2 diabetes mellitus","volume":"1","author":"Jain","year":"2009","journal-title":"J. Diab."},{"key":"10.1016\/j.ejps.2016.12.005_bb0135","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jconrel.2006.04.005","article-title":"A novel calcium silicate based microspheres of repaglinide: in vivo investigations","volume":"113","author":"Jain","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2016.12.005_bb0140","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jconrel.2005.06.007","article-title":"Calcium silicate based microspheres of repaglinide for gastroretentive floating drug delivery: preparation and in vitro characterization","volume":"107","author":"Jain","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2016.12.005_bb0145","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jphotobiol.2015.09.002","article-title":"Rutin nanostructured lipid cosmeceutical preparation with sun protective potential","volume":"153","author":"Kamel","year":"2015","journal-title":"J. Photochem. Photobiol. B Biol."},{"key":"10.1016\/j.ejps.2016.12.005_bb0150","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jdiacomp.2009.09.007","article-title":"Role of lipoic acid on insulin resistance and leptin in experimentally diabetic rats","volume":"25","author":"Kandeil","year":"2011","journal-title":"J. Diabetes Complicat."},{"key":"10.1016\/j.ejps.2016.12.005_bb0155","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S2221-1691(13)60060-X","article-title":"Bioavailability enhancers of herbal origin: an overview","volume":"3","author":"Kesarwani","year":"2013","journal-title":"Asian Pac. J. Trop. Biomed."},{"key":"10.1016\/j.ejps.2016.12.005_bb0160","first-page":"321","article-title":"Alloxan stimulation and subsequent inhibition of insulin release from in situ perfused rat pancreas","volume":"47","author":"Kliber","year":"1996","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.ejps.2016.12.005_bb0165","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0378-5173(83)90064-9","article-title":"Mechanisms of solute release from porous hydrophilic polymers","volume":"15","author":"Korsmeyer","year":"1983","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2016.12.005_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmj.f1654","article-title":"Coronary artery calcium score prediction of all cause mortality and cardiovascular events in people with type 2 diabetes: systematic review and meta-analysis","volume":"346","author":"Kramer","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.ejps.2016.12.005_bb0175","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.ijbiomac.2014.06.011","article-title":"In vitro and in vivo evaluation of novel interpenetrated polymer network microparticles containing repaglinide","volume":"69","author":"Kulkarni","year":"2014","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejps.2016.12.005_bb0180","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.diabet.2013.12.003","article-title":"Metformin accumulation without hyperlactataemia and metformin-induced hyperlactataemia without metformin accumulation","volume":"40","author":"Lalau","year":"2014","journal-title":"Diabete Metab."},{"key":"10.1016\/j.ejps.2016.12.005_bb0185","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0939-6411(98)00015-0","article-title":"Preparation and characterization of nanoparticles containing an antihypertensive agent","volume":"46","author":"Leroueil-Le Verger","year":"1998","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2016.12.005_bb0190","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ijpharm.2014.10.038","article-title":"Preparation, characterization and in vivo evaluation of formulation of repaglinide with hydroxypropyl-beta-cyclodextrin","volume":"477","author":"Liu","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2016.12.005_bb0195","first-page":"421","article-title":"Preparation and characterization of repaglinide loaded ethylcellulose nanoparticles by solvent diffusion technique using high pressure homogenizer","volume":"7","author":"Lokhande","year":"2013","journal-title":"J. Pharm. Res."},{"key":"10.1016\/j.ejps.2016.12.005_bb0200","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijpharm.2006.09.025","article-title":"Curcumin-phospholipid complex: preparation, therapeutic evaluation and pharmacokinetic study in rats","volume":"330","author":"Maiti","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2016.12.005_bb0205","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.jpba.2006.01.056","article-title":"Ionization, lipophilicity and solubility properties of repaglinide","volume":"41","author":"Mandic","year":"2006","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejps.2016.12.005_bb0210","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jcis.2005.06.013","article-title":"Concentration, temperature, and salt-induced micellization of a triblock copolymer Pluronic L64 in aqueous media","volume":"292","author":"Mata","year":"2005","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.ejps.2016.12.005_bb0215","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0939-6411(02)00087-5","article-title":"Atomic force microscopy imaging of novel type of polymeric colloidal nanostructures","volume":"54","author":"Montasser","year":"2002","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2016.12.005_bb0220","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1166\/jbn.2013.1704","article-title":"Micelles of TPGS modified apigenin phospholipid complex for oral administration: preparation, in vitro and in vivo evaluation","volume":"9","author":"Munyendo","year":"2013","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.ejps.2016.12.005_bb0225","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jcis.2007.09.007","article-title":"Self-assembly of beta-casein and lysozyme","volume":"316","author":"Pan","year":"2007","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.ejps.2016.12.005_bb0230","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1472-6882-9-48","article-title":"Evaluation of hypoglycemic and anti-hyperglycemic potential of Tridax procumbens (Linn.)","volume":"9","author":"Pareek","year":"2009","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.ejps.2016.12.005_bb0235","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0378-5173(89)90306-2","article-title":"A simple equation for the description of solute release. III. Coupling of diffusion and relaxation","volume":"57","author":"Peppas","year":"1989","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2016.12.005_bb0240","first-page":"103","article-title":"Phospholipid solubilization of both poorly water-soluble and poorly oil-soluble drug into oils using freeze-drying technology","volume":"1","author":"Qin","year":"2006","journal-title":"AJPS"},{"key":"10.1016\/j.ejps.2016.12.005_bb0245","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/(SICI)1099-0461(2000)14:4<189::AID-JBT2>3.0.CO;2-V","article-title":"Effects of new antioxidant compounds PNU-104067F and PNU-74389G on antioxidant defense in normal and diabetic rats","volume":"14","author":"Rauscher","year":"2000","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.ejps.2016.12.005_bb0250","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1002\/jps.22454","article-title":"In vivo and cytotoxicity evaluation of repaglinide-loaded binary solid lipid nanoparticles after oral administration to rats","volume":"100","author":"Rawat","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2016.12.005_bb0255","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2174\/156720110790396472","article-title":"Development of repaglinide loaded solid lipid nanocarrier: selection of fabrication method","volume":"7","author":"Rawat","year":"2010","journal-title":"Curr. Drug. Deliv."},{"key":"10.1016\/j.ejps.2016.12.005_bb0260","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1002\/jps.22435","article-title":"Studies on binary lipid matrix based solid lipid nanoparticles of repaglinide: in vitro and in vivo evaluation","volume":"100","author":"Rawat","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2016.12.005_bb0265","doi-asserted-by":"crossref","first-page":"224","DOI":"10.2174\/1570163811310030005","article-title":"Baicalein-phospholipid complex: a novel drug delivery technology for phytotherapeutics","volume":"10","author":"Rawat","year":"2013","journal-title":"Curr. Drug Discov. Technol."},{"key":"10.1016\/j.ejps.2016.12.005_bb0270","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S1262-3636(07)70192-1","article-title":"Repaglinide has more beneficial effect on cardiovascular risk factors than glimepiride: data from meal-test study","volume":"31","author":"Rizzo","year":"2005","journal-title":"Diabete Metab."},{"key":"10.1016\/j.ejps.2016.12.005_bb0275","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/j.jpba.2006.12.010","article-title":"Method development and validation of repaglinide in human plasma by HPLC and its application in pharmacokinetic studies","volume":"43","author":"Ruzilawati","year":"2007","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejps.2016.12.005_bb0280","first-page":"8","article-title":"Protective effect of Al-hagi graecorum in alloxan-induced diabetic rats","volume":"8","author":"Salama","year":"2016","journal-title":"Der. Pharma. Chemica"},{"key":"10.1016\/j.ejps.2016.12.005_bb0285","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ijpharm.2015.12.002","article-title":"Influence of surfactants in self-microemulsifying formulations on enhancing oral bioavailability of oxyresveratrol: studies in Caco-2 cells and in vivo","volume":"498","author":"Sangsen","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2016.12.005_bb0290","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jconrel.2009.06.015","article-title":"Hydrotropic oligomer-conjugated glycol chitosan as a carrier of paclitaxel: synthesis, characterization, and in vivo biodistribution","volume":"140","author":"Saravanakumar","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2016.12.005_bb0295","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1472-6882-5-14","article-title":"Antihyperlipidemic and antiperoxidative effect of Diasulin, a polyherbal formulation in alloxan induced hyperglycemic rats","volume":"5","author":"Saravanan","year":"2005","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.ejps.2016.12.005_bb0300","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2165\/11207600-000000000-00000","article-title":"Repaglinide","volume":"72","author":"Scott","year":"2012","journal-title":"Drugs"},{"key":"10.1016\/j.ejps.2016.12.005_bb0305","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1208\/s12249-008-9057-5","article-title":"Micellar solubilization of some poorly soluble antidiabetic drugs: a technical note","volume":"9","author":"Seedher","year":"2008","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejps.2016.12.005_bb0310","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1517\/17425240902967607","article-title":"Pharmacosomes: the lipid-based new drug delivery system","volume":"6","author":"Semalty","year":"2009","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejps.2016.12.005_bb0315","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2478\/v10007-009-0023-x","article-title":"Development and physicochemical evaluation of pharmacosomes of diclofenac","volume":"59","author":"Semalty","year":"2009","journal-title":"Acta Pharm."},{"key":"10.1016\/j.ejps.2016.12.005_bb0320","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jsps.2015.02.013","article-title":"In-vitro and in-vivo evaluation of repaglinide loaded floating microspheres prepared from different viscosity grades of HPMC polymer","volume":"23","author":"Sharma","year":"2015","journal-title":"Saudi Pharma. J."},{"key":"10.1016\/j.ejps.2016.12.005_bb0325","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ijpharm.2013.10.043","article-title":"Novel rifampicin-phospholipid complex for tubercular therapy: synthesis, physicochemical characterization and in-vivo evaluation","volume":"460","author":"Singh","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2016.12.005_bb0330","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1166\/jbn.2007.001","article-title":"Dissolution rates and supersaturation behavior of amorphous repaglinide particles produced by controlled precipitation","volume":"3","author":"Sinswat","year":"2007","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.ejps.2016.12.005_bb0335","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1248\/yakushi1947.117.12_1022","article-title":"Trial for transdermal administration of sulfonylureas","volume":"117","author":"Takahashi","year":"1997","journal-title":"J. Pharm. Soc. Jpn."},{"key":"10.1016\/j.ejps.2016.12.005_bb0340","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1208\/s12249-012-9772-9","article-title":"Design and evaluation of a novel evodiamine-phospholipid complex for improved oral bioavailability","volume":"13","author":"Tan","year":"2012","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejps.2016.12.005_bb0345","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11095-006-9132-0","article-title":"Micellar nanocarriers: pharmaceutical perspectives","volume":"24","author":"Torchilin","year":"2007","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2016.12.005_bb0350","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.colsurfb.2013.05.020","article-title":"Optimization and characterization of repaglinide biodegradable polymeric nanoparticle loaded transdermal patches: in vitro and in vivo studies","volume":"111","author":"Vijayan","year":"2013","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.ejps.2016.12.005_bb0355","doi-asserted-by":"crossref","first-page":"545","DOI":"10.2147\/IJN.S39526","article-title":"A novel drug-phospholipid complex enriched with micelles: preparation and evaluation in vitro and in vivo","volume":"8","author":"Xia","year":"2013","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ejps.2016.12.005_bb0360","doi-asserted-by":"crossref","first-page":"340315","DOI":"10.1155\/2013\/340315","article-title":"Polymeric micelles, a promising drug delivery system to enhance bioavailability of poorly water-soluble drugs","volume":"2013","author":"Xu","year":"2013","journal-title":"J. Drug Deliv."},{"key":"10.1016\/j.ejps.2016.12.005_bb0365","first-page":"172","article-title":"Effect of repaglinide and gliclazide on glycaemic control, early-phase insulin secretion and lipid profiles in","volume":"124","author":"Zhang","year":"2011","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.ejps.2016.12.005_bb0370","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jpba.2015.05.017","article-title":"Preparation and evaluation of kaempferol-phospholipid complex for pharmacokinetics and bioavailability in SD rats","volume":"114","author":"Zhang","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejps.2016.12.005_bb0375","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/10717540701203034","article-title":"Preparation and characterization of solid lipid nanoparticles containing silibinin","volume":"14","author":"Zhang","year":"2007","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejps.2016.12.005_bb0380","first-page":"4169","article-title":"Preparation and characterization of tetrandrine-phospholipid complex loaded lipid nanocapsules as potential oral carriers","volume":"8","author":"Zhao","year":"2013","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ejps.2016.12.005_bb0385","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.1021\/jf010697n","article-title":"Antioxidant activity and phenolic compounds in selected herbs","volume":"49","author":"Zheng","year":"2001","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejps.2016.12.005_bb0390","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084530","article-title":"A new strategy for enhancing the oral bioavailability of drugs with poor water-solubility and low liposolubility based on phospholipid complex and supersaturated SEDDS","volume":"8","author":"Zhou","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejps.2016.12.005_bb0395","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ajps.2014.06.004","article-title":"A simple method to improve the dissolution of\u0622 repaglinide and exploration of its mechanism","volume":"9","author":"Zhu","year":"2014","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2016.12.005_bb0400","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1111\/dme.12269","article-title":"Prevalence of type 2 diabetes and pre-diabetes among overweight or obese children in Tianjin, China","volume":"30","author":"Zhu","year":"2013","journal-title":"Diabet. Med."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098716305322?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098716305322?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T16:25:56Z","timestamp":1536164756000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098716305322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":80,"alternative-id":["S0928098716305322"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2016.12.005","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phospholipid complex enriched micelles: A novel drug delivery approach for promoting the antidiabetic effect of repaglinide","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2016.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}